Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.
about
Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.Tacrolimus-based versus cyclosporine-based immunosuppression in hepatitis C virus-infected patients after liver transplantation: a meta-analysis and systematic review.Model for end-stage liver disease-based allocation system for liver transplantation in Argentina: does it work outside the United States?Management of hepatitis C in patients with chronic kidney disease.Major challenges limiting liver transplantation in the United States.Systematic Review and Meta-Analysis of Tacrolimus versus Ciclosporin as Primary Immunosuppression After Liver TransplantCyclophilin inhibitors in hepatitis C viral infection.Investigational drugs for hepatitis C.Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response.Enhanced apoptosis in post-liver transplant hepatitis C: effects of virus and immunosuppressantsRecurrent hepatitis C virus infection post liver transplantation: impact of choice of calcineurin inhibitor.Management of Hepatitis C Before and After Liver Transplantation in the Era of Rapidly Evolving Therapeutic Advances.REFINE: a randomized trial comparing cyclosporine A and tacrolimus on fibrosis after liver transplantation for hepatitis C.Specifically targeted antiviral therapy for hepatitis C virus.
P2860
Q34093754-CD657DFE-E0C4-4D3A-BB62-187F01A6349FQ34150039-5F02F81B-F0FB-425F-A060-BF40988E0153Q34538837-5368DED3-F687-47EB-8DFB-44E99B75555DQ34932338-F35EF41B-C9BF-4F25-BB8D-3CB36E0C4AA5Q35194675-61E2F48F-12AF-49BF-9C4A-5F3F24C38382Q36182011-79614F7A-FB61-47CC-AE4C-346F2884BEACQ36916858-466DA81E-8E7C-4303-92ED-89C9AE530ACEQ37650377-50D34C30-699C-43C6-8ACF-3AF47DB3B16FQ37798839-FF17F788-B2BA-4140-BA66-9CD0EA512961Q38011694-4555DDE7-0714-4E4C-9CA5-7A9E5711A74AQ38081919-9B290EFB-B016-4718-AF36-AAAB9D92C752Q38584289-771C3C90-2F7B-4CA1-A089-DDD3C4DF7CA0Q42241628-576FC49F-1A79-429D-913A-8D45E21E08EFQ42909514-1325D99F-F18F-4430-B233-AFA68437DBC4
P2860
Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Long-term outcomes in liver tr ...... ng tacrolimus or cyclosporine.
@en
Long-term outcomes in liver tr ...... ng tacrolimus or cyclosporine.
@nl
type
label
Long-term outcomes in liver tr ...... ng tacrolimus or cyclosporine.
@en
Long-term outcomes in liver tr ...... ng tacrolimus or cyclosporine.
@nl
prefLabel
Long-term outcomes in liver tr ...... ng tacrolimus or cyclosporine.
@en
Long-term outcomes in liver tr ...... ng tacrolimus or cyclosporine.
@nl
P2093
P50
P1476
Long-term outcomes in liver tr ...... ing tacrolimus or cyclosporine
@en
P2093
Leonardi L
Mühlbacher F
Villamil F
P304
P356
10.1016/J.TRANSPROCEED.2006.08.131
P407
P577
2006-11-01T00:00:00Z